Follow-up and surveillance for people after treatment for bowel cancer

Bowel cancer is a leading cause of cancer mortality in New Zealand,...

Surveillance for people with polyps or inflammatory bowel disease

Guidance for following up people who have had polyps identified...

Cancer care: the role of primary care in identifying and managing cachexia

Through improvements in diagnosis and treatment, one in three...

Early detection of lung cancer in primary care

Lung cancer is one of the most common cancers in New Zealand...

National report: Testing for prostate cancer in primary care

This report provides an overview of laboratory prostate-specific...

Referral of patients with features suggestive of bowel cancer: Ministry of Health guidance

Bowel cancer is one of the most common causes of cancer death...

Testing for prostate cancer: helping patients to decide

Testing for prostate cancer is a difficult issue as many prostate...

Biosimilars: the future of prescribing biological medicines

Biological medicines are an important advancement in the pharmaceutical...

Reducing the burden of melanoma in New Zealand Part 1: Prevention and risk assessment

Limiting UV radiation exposure through sun smart behaviour is...

Reducing the burden of melanoma in New Zealand Part 2: Early detection of melanoma

Identification of melanoma at the earliest possible clinical...

HPV vaccination: getting the programme back on track

Vaccination against human papillomavirus (HPV) infection provides...

Hereditary diffuse gastric cancer: an overview for primary care

Hereditary diffuse gastric cancer makes up around 1% of stomach...

Kupe from the Medtech tool bar

Kupe is freely available on the web and we would also like to...

Prostate cancer testing decision support tool for patients and their families

Discussing the pros and cons of prostate cancer testing within...

Immune checkpoint inhibitors: a new cancer treatment

Immune checkpoint inhibitors, such as pembrolizumab (Keytruda),...

How to use fluorouracil and imiquimod for non-melanoma skin cancer in a general practice setting

Fluorouracil and imiquimod creams are fully subsidised topical...

Improving the safety of community-based chemotherapy

Improving the safety of community-based chemotherapy

Chemotherapy is predominantly managed in secondary care, but...

An HPV update: vaccination coverage needs to be improved

Vaccination against human papillomaviruses (HPV) is fully subsidised...

The New Zealand Laboratory Schedule and Test Guidelines: Anatomic Pathology Tests

The New Zealand Laboratory Schedule provides clinicians with...

Melanoma of the foot

Acral melanoma is a subtype of cutaneous melanoma, which manifests...

The New Zealand Laboratory Schedule and Test Guidelines: genetic tests

The New Zealand Laboratory Schedule provides clinicians with...

News Updates

This article has been archived. If you would like access...

News Updates

Does aspirin protect against cancer? More high-quality research...

Managing non-melanoma skin cancer in primary care: A focus on topical treatments

When a patient presents with a suspicious skin lesion the first...

How to increase the uptake of cervical screening: A profile of success

A cervical smear test is an effective method for the early detection...

Health literacy plays an important role in boosting cervical screening uptake

Susan Reid and Carla White from health literacy and communication...

Cervical Screening – Are we reaching our targets?

There are approximately 180 new diagnoses of cervical cancer...

Interpreting urine dipstick tests in adults: a reference guide for primary care

A urine dipstick positive for haematuria or proteinuria is a...

Upfront: Lung cancer in New Zealand

Lung cancer in New Zealand: overcoming barriers

Following up prostate cancer in primary care

Cancer services in New Zealand are undergoing major changes...

A new model for cancer care in New Zealand

An ageing population, earlier diagnosis and advances in oncology...

Appropriate use of the faecal occult blood test for colorectal cancer

What is a faecal occult blood test? When should a faecal occult...

Surveillance of people at increased risk of colorectal cancer

The incidence of colorectal cancer in New Zealand is high by...

The HPV vaccination programme: addressing low uptake

The human papillomavirus (HPV) vaccine was added to the national...

PHO Performance Programme - six years on

The PHO Performance Programme was established in 2005 to improve...

Making sense of serum protein bands

Serum protein bands (monoclonal gammopathy) will sometimes be...

Increasing the uptake of breast screening

Significant progress has been made in increasing the rate of...

Detecting malignant melanoma

New Zealand has one of the highest rates of melanoma in the...

Overcoming barriers to cervical screening in Pacific women

Cervical screening rates in New Zealand have continued to increase...

Appropriate use of tumour markers

The key role for tumour marker tests is in managing patients...

Bowel cancer screening in New Zealand

Progress to date on a national screening programme for bowel...

PSA screening in asymptomatic men

Prostate cancer screening in asymptomatic men is a controversial...

The use of screening tests

GPs frequently perform tests for screening purposes, whether...

Smoking related cancer morbidity and mortality

The majority of people with cancer will initially present to...

Breast screening - achieving equity

Breast cancer is the leading cause of cancer death in New Zealand...

Cervical Screening in New Zealand

Liquid-based cytology (LBC) and Human Papillomavirus (HPV) testing...

Cervical smears - achieving equity

After the introduction of the National Cervical Screening Programme,...

Gardasil vaccine: Update

Gardasil vaccine has now been added to the National Immunisation...

Upfront: The unequal impact of cancer.

Cancer has a significant and disproportionate impact on Māori,...

Imiquimod cream (Aldara) for genital warts and basal cell carcinoma

Imiquimod enhances the immune response to viral infections and...

HPV vaccines: An overview

Dr Nikki Turner is the Director of the Immunisation Advisory...

Herceptin the facts

A focus on the clinical issues surrounding the use of Herceptin...